oncology

Tampa General Hospital Cancer Institute will integrate Reimagine's platform into its clinical pathways to reduce workforce burden and extend cancer care into the home.

The partnership comes three months after Thyme Care raised $97 million in funding, bringing its total raise to $275 million.

The Series D funding brings the company’s total raise to $275 million and its valuation to more than $1 billion.

Julien Payen, cofounder and CEO of Lattice Medical, describes the company's 3D-printed, resorbable breast implant that uses a patient's own fat to regenerate natural breast tissue after a mastectomy.

The collaboration will increase the use cases for healthcare professionals to create care protocols and new treatments in oncology and promote precision medicine.

The alliance combines ConcertAI's data platform with Bayer's scientific and AI expertise.

Notable partners with CityMD, and Bamboo Health join forces with Ohio to strengthen its prescription drug monitoring system.  

DeepScribe will be the first ambient AI partner for Flatiron Health, and will integrate with Flatiron's OncoEMR.   

Cancer patients and caregivers will receive free access to an AI-enabled app for mental health and other support services.

Jennifer Goldsack, CEO of the Digital Medicine Society (DiMe) and cohost of CancerX, highlights ONC's annual meeting and how data with interoperability, privacy and security protections can fundamentally change oncology outcomes.